Found 21 matching trials
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
PHASE1CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Location
Children's Hospital, Zhejiang University School of Medicine
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma
NAThe goal of this clinical trial is to estimate the safety, tolerance and in...
Location
The Second Affiliated Hospital of Soochow University
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
EARLY_PHASE1This is an exploratory, open-label, single-arm clinical study designed to e...
Location
Children's Hospital, Zhejiang University School of Medicine
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
Children's Hospital, Zhejiang University School of Medicine
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
EARLY_PHASE1This is an open label, single-site, dose-escalation study in up to 18 parti...
Location
The first affiliated hospital of medical college of zhejiang university
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
Regenerative Medicine Center and Red Blood Cell Disorders Center
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
PHASE1This is a single-center, single-arm ,open-label ,dose escalation and dose e...
Location
Multiple Locations
The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)
EARLY_PHASE1This is a single arm, open-label, single center, exploratory clinical study...
Location
The Affiliated Hospital of Xuzhou Medical University
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
EARLY_PHASE1This is an open label, single-site, dose-escalation study in up to 12 parti...
Location
Tianjin Huanhu Hospital